<abstract xmlns="http://www.w3.org/1999/xhtml">

<p>Bovine Respiratory Syncytial Virus (BRSV), Bovine Parainfluenza 3 (BPI3) and <italic>Mannheimia haemolytica (Mh)</italic> are major respiratory pathogens in the bovine respiratory disease complex. It is important to optimize passive and active immunity to these pathogens early in life to reduce clinical and subclinical productivity losses. The administration of inactivated, adjuvanted and multivalent vaccines, such as Bovilis® Bovipast RSP (Bovipast), and Bovalto® Respi 3 (Bovalto) to calves, may enhance cellular and humoral immunity against BRSV, BPI3 and <italic>Mh.</italic> A field trial evaluated the immune responses to these three agents in the first year of life in 12 Bovipast and 13 Bovalto vaccinated calves, and 5 negative control calves. Calves were vaccinated starting at 2 weeks of age and revaccinated 4 weeks later (primo vaccination). A booster vaccination was given at approximately 10 months of age. Serum samples were taken at time intervals up to 6 months after primo vaccination and up to 1 month after the booster vaccination. BRSV serum titres were evaluated using a serum neutralisation assay (SN), and BRSV, BPI3 and <italic>Mh</italic> titres were evaluated using a commercial enzyme linked immunosorbent assay (ELISA) test. Serum antibodies after primo and booster vaccinations in the individual calves were evaluated by calculating the areas under the curve (AUC) of the Log2 transformed BRSV SN titres and the optic density measures of the ELISA tests for BRSV, BPI3 and <italic>Mh.</italic> Multivariate general linear models were used to evaluate the influence of the vaccination on the AUC of the serum measures within 6 months after the primo vaccination. Similarly, models evaluated the AUC of the serum measures after the booster vaccination. The Bovipast vaccinated calves had significantly higher SN and ELISA titres AUC following the primo vaccination and booster vaccinations compared to the negative control calves and the Bovalto vaccinated calves. The Bovalto vaccinated calves did not have a significantly different BRSV SN and ELISA titres AUC response after the primo or booster vaccinations compared to the negative control calves. The serum antibody responses to BPI3 and <italic>Mh</italic> in the vaccinated calves were less pronounced than the Bovipast BRSV antibody response. Bovipast and Boval- to vaccinated calves mounted a significantly higher AUC ELISA OD for both BPI3 and <italic>Mh</italic> and the highest AUC was measured in the Bovipast vaccinated calves. This study indicated that early vaccinations of calves with multivalent adjuvanted inactivated BRD vaccines, such as Bovilis® Bovipast RSP can elicit a humoral response with a cellular-mediated memory effect as indicated by the booster vaccination.</p>
</abstract>

Bovine Respiratory Syncytial Virus (BRSV), Bovine Parainfluenza 3 (BPI3) and Mannheimia haemolytica (Mh) are major respiratory pathogens in the bovine respiratory disease complex. It is important to optimize passive and active immunity to these pathogens early in life to reduce clinical and subclinical productivity losses. The administration of inactivated, adjuvanted and multivalent vaccines, such as Bovilis® Bovipast RSP (Bovipast), and Bovalto® Respi 3 (Bovalto) to calves, may enhance cellular and humoral immunity against BRSV, BPI3 and Mh. A field trial evaluated the immune responses to these three agents in the first year of life in 12 Bovipast and 13 Bovalto vaccinated calves, and 5 negative control calves. Calves were vaccinated starting at 2 weeks of age and revaccinated 4 weeks later (primo vaccination). A booster vaccination was given at approximately 10 months of age. Serum samples were taken at time intervals up to 6 months after primo vaccination and up to 1 month after the booster vaccination. BRSV serum titres were evaluated using a serum neutralisation assay (SN), and BRSV, BPI3 and Mh titres were evaluated using a commercial enzyme linked immunosorbent assay (ELISA) test. Serum antibodies after primo and booster vaccinations in the individual calves were evaluated by calculating the areas under the curve (AUC) of the Log2 transformed BRSV SN titres and the optic density measures of the ELISA tests for BRSV, BPI3 and Mh. Multivariate general linear models were used to evaluate the influence of the vaccination on the AUC of the serum measures within 6 months after the primo vaccination. Similarly, models evaluated the AUC of the serum measures after the booster vaccination. The Bovipast vaccinated calves had significantly higher SN and ELISA titres AUC following the primo vaccination and booster vaccinations compared to the negative control calves and the Bovalto vaccinated calves. The Bovalto vaccinated calves did not have a significantly different BRSV SN and ELISA titres AUC response after the primo or booster vaccinations compared to the negative control calves. The serum antibody responses to BPI3 and Mh in the vaccinated calves were less pronounced than the Bovipast BRSV antibody response. Bovipast and Boval- to vaccinated calves mounted a significantly higher AUC ELISA OD for both BPI3 and Mh and the highest AUC was measured in the Bovipast vaccinated calves. This study indicated that early vaccinations of calves with multivalent adjuvanted inactivated BRD vaccines, such as Bovilis® Bovipast RSP can elicit a humoral response with a cellular-mediated memory effect as indicated by the booster vaccination.

A Field Study Evaluating Humoral Immunity in Calves Vaccinated with Multivalent Bovine Respiratory Pathogen Vaccines

Folia Veterinaria

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Bovine Respiratory Syncytial Virus (BRSV), Bovine Parainfluenza 3 (BPI3) and Mannheimia haemolytica (Mh) are major respiratory pathogens in the bovine...

A Field Study Evaluating Humoral Immunity in Calves Vaccinated with Multivalent Bovine Respiratory Pathogen Vaccines

Pubblicato online: 30 dic 2021

Pagine: 20 - 30

Ricevuto: 02 set 2021

Accettato: 11 ott 2021

DOI: https://doi.org/10.2478/fv-2021-0034

© 2021 Ioannis Chrysikos, published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.